|
Hereditary diseases are caused by
alterations (mutations) in the sequence of
the genetic material (DNA) that each
individual carries within their cells. These
mutation do not only cause disease in the
individual carrying them, but can be
inherited and cause disease in subsequent
generations.
The
molecular diagnostic assays employed in the
Molecular Genetics Laboratory provide a
direct approach to determine weather an
individual carries a disease associated gene
mutation. These tests are particularly well
suited diagnosis, pre-symptomatic diagnosis,
carrier detection, and genetic screening.
The
Molecular Genetics Laboratory provides
prenatal and postnatal diagnosis for certain
inherited disorders and diagnosis of carrier
status for different hereditary disorders.
In Addition, determination of genetic
susceptibility and predisposition to
multi-factorial diseases is offered.
Currently we provide genetic testing for the
following:
 |
Angiotensin I
Converting Enzyme (ACE)
|
 |
Cadacil (Cerebral
Autosomal Dominant Arteropathy with
Subcortical Infracts and
Leucoencephalopathy) |
 |
Cystic Fibrosis
|
 |
Factor V Leiden
|
 |
Familial Mediterranean
Fever (FMF) |
 |
Fragile X Syndrome
|
 |
Gaucher Disease
|
 |
Hereditary
Hemochromatosis |
 |
Huntington’s Disease
(HD) |
 |
Methylene
Tetrahydrofolate Redutase (MTHFR)
|
 |
Mitochondrial
Encephalmyopathy with Lactic Acidosis (MELAS)
|
 |
Mitochondrial
Inheritance Diabetes Melitus with Deafness
|
 |
Multiple Endocrine
Neoplasia Type 2 (MEN) |
 |
Myetonic Dystrophy
|
 |
Prothrombrin G20210A
variant |
 |
Sickle Cell Anemia
|
The
laboratory’s ability to identify new
diseases casing mutations as well as
detecting the presence of known and
well-established pathogenic mutations, makes
it unique in the DNA diagnostic field in the
Middle East.
The
research group is constantly working towards
the development of unprecedented testing
methodologies and towards expanding the
spectrum and number of diseases diagnosed
through molecular DNA testing. Thus, the
laboratory not only offers diagnostic
services for the detection of mutations, but
also is engaged in mutation identification
and determination of the frequency of these
mutations amongst the Arab population.
Since the
laboratory was established six years ago it
has participated successfully in the College
of American Pathologist Proficiency testing
program (external qulity control) for each
analyte tested. The laboratory is also a
member of the American Association for
Laboratory Accreditation. This ensures that
all diagnostic tests, run by the laboratory,
reach highest international standards.
|